Back to top

Top Stock Picks for Week of August 3, 2020

Read MoreHide Full Article

Crocs, Inc. (CROX - Free Report) , is a world leader in innovative casual footwear for men, women and children. At present, this high performance stock has an expected long-term earnings growth rate of 15% and a Zacks Rank #1 (Strong Buy). With a Zacks Growth Style Score of “A”, Crocs offers a broad portfolio of all-season products, while remaining true to its core molded footwear heritage. Fans of Crocs stick with the brand, which has helped the company excel in the pandemic though online sales. The company reported EPS recently, seeing an EPS beat of triple digits. Revenue also beat substantially. Margins ticked higher, but the big beat could be attributed to the 67% year over year growth in e-commerce.

NVIDIA Corporation (NVDA - Free Report) , is the worldwide leader in visual computing technologies and the inventor of the graphic processing unit, or GPU. NVIDIA is benefiting from the coronavirus-induced work from home and learn-at-home wave. The company is also benefiting from strong growth in GeForce desktop and notebook GPUs, which is boosting gaming revenues. Moreover, a surge in Hyperscale demand remains a tailwind for the company’s Data Center business.  NVIDIA is a cash rich company with a strong balance sheet. NVIDIA boasts a sturdy cash-flow generating ability. The company’s accelerated revenue growth along with improving operating efficiency is bringing in higher cash flows. The higher cash flow generating ability lends NVIDIA flexibility to invest in the long-term growth prospects and return money to its shareholders. 

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


NVIDIA Corporation (NVDA) - free report >>

Crocs, Inc. (CROX) - free report >>

Published in